Pingyuan Yang

2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder

Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism

A Novel Urinary Metabolite Signature for Diagnosing Major Depressive Disorder

Identification and Validation of Urinary Metabolite Biomarkers for Major Depressive Disorder

Plasma Metabonomics as a Novel Diagnostic Approach for Major Depressive Disorder

Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?

The role of short-chain fatty acids in microbiota–gut–brain communication

Potential metabolite markers of schizophrenia